Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc. (SNDX) — Form 10-Q: Quarterly report
About this filing
Syndax Pharmaceuticals, Inc. (SNDX) filed Form 10-Q (quarterly report) with the SEC on Aug 4, 2026. A 10-Q is the company’s quarterly financial report.
Key facts
- Document
- 10-Q
More SNDX filings
- 4
Filed Oct 30, 2026
- 144
Filed Oct 29, 2026
- SC 13G
Filed Aug 7, 2026
- 8-K
Filed Aug 4, 2026
- 8-K
Filed Jul 14, 2026
- 4
Filed Jul 9, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.